Cargando…
Lithium Carbonate in the Treatment of Graves' Disease with ATD-Induced Hepatic Injury or Leukopenia
Objective. GD with ATD-induced hepatic injury or leukopenia occurs frequently in clinical practice. The purpose of the present study was to observe the clinical effect of lithium carbonate on hyperthyroidism in patients with GD with hepatic injury or leukopenia. Methods. Fifty-one patients with GD w...
Autores principales: | Zheng, Rendong, Liu, Kemian, Chen, Kun, Cao, Wen, Cao, Lin, Zhang, Huifeng, Sun, Hongping, Liu, Chao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4630389/ https://www.ncbi.nlm.nih.gov/pubmed/26576153 http://dx.doi.org/10.1155/2015/694023 |
Ejemplares similares
-
Risk Factors for Hypogonadism in Male Patients with Type 2 Diabetes
por: Zheng, Rendong, et al.
Publicado: (2016) -
THU670 Serum TSI Concentration In Patients With Graves’ Disease Undergoing Maintenance-dose Of Antithyroid Drug (ATD) And Its Relationship With Disease Relapse After ATD Withdrawal
por: Nhat Nguyen, Phong Vu, et al.
Publicado: (2023) -
ATD Talent Management Handbook
por: Bickham, Terry
Publicado: (2015) -
A case of antithyroid drug‐induced agranulocytosis from a second antithyroid drugs (ATD) administration in a relapsed Graves' disease patient who was tolerant to the first ATD treatment
por: Kim, Hyunsam, et al.
Publicado: (2018) -
ATD's 2020 Trends in Learning Technology
por: Brusino et al, Justin
Publicado: (2020)